Will Insurance Companies Cover The New Cgrp Drug?
Yay! The FDA has approved Amgen and Novartis' CGRP preventive medication, Aimovig, for the prevention of migraine. But how accessible will this new medication be to patients? Will our insurance companies prevent us from even getting them? Global Healthy Living Foundation takes a look at some of the possible obstacles getting access to it.
Read the article at ow.ly/oBSv30k4OJs
Join the 50-State Network to fight back against these insurance company practices. Let’s make sure everyone who needs these new treatments can get them. Click on the image below to get started!
